US03969F1093
US03969F1093
Arcus Biosciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 247.000.000 | 258.000.000 | 4.3% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 633.000.000 | 568.000.000 | 11.4% | |
| Operating Income | -386.000.000 | -310.000.000 | 24.5% |
| Pretax Income | -353.000.000 | -282.000.000 | 25.2% |
| Net Income Common Stockholders | -353.000.000 | -283.000.000 | 24.7% |
| -- | -- | -- | |
| -- | -- | -- |